Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$856M |
| 2 |
Meta Platforms (Facebook)
META
|
+$647M |
| 3 |
NVIDIA
NVDA
|
+$615M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$304M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.03B |
| 2 |
UnitedHealth
UNH
|
+$686M |
| 3 |
Tesla
TSLA
|
+$387M |
| 4 |
Abbott
ABT
|
+$380M |
| 5 |
Chevron
CVX
|
+$328M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.26% |
| 2 | Healthcare | 16.96% |
| 3 | Consumer Discretionary | 12.82% |
| 4 | Consumer Staples | 9.14% |
| 5 | Industrials | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DAO
3251
Youdao
DAO
$2.15B
| $226K | ﹤0.01% |
46,800
+12,200
| +35% | +$67.6K |
|
3252
Legacy Housing
LEGH
$690M
| $225K | ﹤0.01% |
9,700
-19,608
| -67% | -$425K |
|
3253
Vista Gold
VGZ
$326M
| $225K | ﹤0.01% |
433,600
+32,332
| +8% | +$19.7K |
|
|
ZYNE
3254
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $225K | ﹤0.01% |
689,713
+120,013
| +21% | +$43K |
|
3255
Investar Holding Corp
ISTR
$428M
| $224K | ﹤0.01% |
18,475
-100
| -0.5% | -$1.23K |
|
3256
Retractable Technologies
RVP
$20.2M
| $224K | ﹤0.01% |
195,171
+33,947
| +21% | +$48.6K |
|
|
SWKH
3257
DELISTED
SWK Holdings
SWKH
| $224K | ﹤0.01% |
16,911
-252
| -1% | -$3.45K |
|
3258
Brookfield Renewable
BEP
$10.5B
| $223K | ﹤0.01% |
7,552
-13,798
| -65% | -$424K |
|
3259
AmpliTech
AMPG
$158M
| $222K | ﹤0.01% |
+96,279
| New | +$263K |
|
3260
Capricor Therapeutics
CAPR
$254M
| $222K | ﹤0.01% |
46,421
+15,900
| +52% | +$69.9K |
|
3261
Vanguard S&P Small-Cap 600 Value ETF
VIOV
$1.91B
| $222K | ﹤0.01% |
2,700
-2,900
| -52% | -$229K |
|
|
VIVS
3262
VivoSim Labs
VIVS
$1.15M
| $221K | ﹤0.01% |
10,887
-70
| -0.6% | -$1.58K |
|
3263
Avalon Holdings
AWX
$10.6M
| $220K | ﹤0.01% |
86,210
-800
| -0.9% | -$2.02K |
|
3264
Vanguard Health Care ETF
VHT
$19B
| $220K | ﹤0.01% |
900
-7,700
| -90% | -$1.87M |
|
3265
John Hancock Multifactor Mid Cap ETF
JHMM
$6.17B
| $219K | ﹤0.01% |
+4,400
| New | +$209K |
|
3266
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.66B
| $219K | ﹤0.01% |
5,800
-16,000
| -73% | -$590K |
|
3267
Alerus Financial
ALRS
$846M
| $218K | ﹤0.01% |
+12,100
| New | +$196K |
|
3268
Invesco S&P 500 Equal Weight Consumer Staples ETF
RSPS
$248M
| $218K | ﹤0.01% |
+6,500
| New | +$222K |
|
|
DOMA
3269
DELISTED
Doma Holdings, Inc.
DOMA
| $218K | ﹤0.01% |
44,107
+2,647
| +6% | +$21.2K |
|
|
LLAP
3270
DELISTED
Terran Orbital Corporation
LLAP
| $217K | ﹤0.01% |
+144,500
| New | +$229K |
|
3271
Auburn National Bancorp
AUBN
$91.1M
| $216K | ﹤0.01% |
10,141
+800
| +9% | +$17.4K |
|
|
VZLA
3272
Vizsla Silver
VZLA
$1.31B
| $216K | ﹤0.01% |
176,800
+160,100
| +959% | +$215K |
|
3273
Acumen Pharmaceuticals
ABOS
$178M
| $215K | ﹤0.01% |
44,800
+7,355
| +20% | +$35.2K |
|
3274
South Plains Financial
SPFI
$860M
| $214K | ﹤0.01% |
+9,500
| New | +$206K |
|
3275
AZZ Inc
AZZ
$4.55B
| $213K | ﹤0.01% |
4,900
-3,600
| -42% | -$138K |
|
Similar funds
Jim Simons's Q2 2023 Portfolio in Review
As of Q2 2023, Jim Simons held 4,468 positions worth $69.4B, down 7.9% from $75.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons withdrew a net $8.1B in Q2 2023, closing 599 positions and reducing 1,691 holdings. Its most notable exit was UnitedHealth, an estimated $686M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in Berkshire Hathaway Class A worth $316M.
- Jim Simons's largest Q2 2023 buy was Berkshire Hathaway Class A: 611 shares worth $316M.
- Jim Simons added most to Apple in Q2 2023, an estimated $856M increase.
- Jim Simons's biggest Q2 2023 reduction was Amazon, cutting an estimated $1.03B.
- Jim Simons fully exited UnitedHealth in Q2 2023, selling an estimated $686M.
- Jim Simons's ten largest holdings make up 12% of its $69.4B portfolio in Q2 2023.
- Jim Simons opened 541 new positions and closed 599 in Q2 2023.
- Jim Simons's portfolio value fell 7.9% quarter-over-quarter to $69.4B.
Based on Renaissance Technologies's 13F filing for Q2 2023, filed 11 Aug 2023.